Sweet dreams?--nocturnal hypoglycemia in children with type 1 diabetes

Krystyna A Matyka1

  • 1Division of Medicine, Division of Medical Sciences, University of Birmingham, Birmingham Heartlands Hospital, Birmingham, UK. k.a.matyka@bham.ac.uk

Pediatric Diabetes
|March 16, 2004
PubMed

Insights

Nocturnal hypoglycemia in children with type 1 diabetes presents unique physiological challenges. Understanding these differences is key to developing effective avoidance strategies for this serious complication.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Sleep Physiology

Background:

  • Hypoglycemia is a common complication in childhood type 1 diabetes treatment.
  • Nocturnal hypoglycemia is often underestimated but may have distinct physiological underpinnings.
  • Current understanding of nocturnal hypoglycemia's specific risks and management is limited.

Purpose of the Study:

  • To explore the unique physiological factors contributing to nocturnal hypoglycemia in children with type 1 diabetes.
  • To investigate how sleep physiology impacts glucose homeostasis during fasting and post-exercise periods.
  • To highlight the need for further research into the etiology and repercussions of nocturnal hypoglycemia.

Main Methods:

  • Review of existing literature on glucose metabolism during sleep in pediatric populations.
  • Analysis of physiological changes during fasting and their interaction with sleep.
  • Examination of the delayed effects of exercise on nocturnal glucose levels.

Main Results:

  • Nocturnal hypoglycemia may be more profound and prolonged due to altered glucose homeostasis during sleep.
  • Factors like fasting, exercise, and sleep stage influence the risk and severity of nocturnal hypoglycemia.
  • The body's ability to correct falling glucose levels may be impaired during sleep.

Conclusions:

  • Nocturnal hypoglycemia in type 1 diabetes is a complex phenomenon requiring specialized understanding.
  • Further research is essential to elucidate the precise mechanisms and develop targeted avoidance strategies.
  • Improved comprehension is critical for enhancing patient safety and treatment efficacy in pediatric diabetes management.

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Nightmares and Night Terrors01:18

Nightmares and Night Terrors

Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares often...